What is Regenxbio's interest coverage?

Regenxbio (RGNX) reported interest coverage of -5.7× in Q1 2026.

How has Regenxbio's interest coverage changed year-over-year?

Regenxbio's interest coverage increased by 30.4% year-over-year, from -8.2× to -5.7×.

What is the long-term trend for Regenxbio's interest coverage?

Over 5 years (2020 to 2025), Regenxbio's interest coverage has grown at a -52.9% compound annual growth rate (CAGR), from -154.6× to -3.6×.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Regenxbio RGNX Interest coverage

Interest coverage at other companies

Regeneron PharmaceuticalsREGN

75.6×-4.5×

BioMarin PharmaceuticalsBMRN

15.8×-35.9×

EyePoint, Inc. EYPT

-7,376.8×—

Solid Biosciences Inc.SLDB

-550.3×-4,335×

PrecigenPGEN

-22,521.4×-22,838×

Viridian Therapeutics, Inc.VRDN

-49.3×-20.0×

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Calculated from Regenxbio’s reported figures.

ebit/interest expense=-5.7×

Based on trailing twelve months.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's interest coverage?: Regenxbio (RGNX) reported interest coverage of -5.7× in Q1 2026.
How has Regenxbio's interest coverage changed year-over-year?: Regenxbio's interest coverage increased by 30.4% year-over-year, from -8.2× to -5.7×.
What is the long-term trend for Regenxbio's interest coverage?: Over 5 years (2020 to 2025), Regenxbio's interest coverage has grown at a -52.9% compound annual growth rate (CAGR), from -154.6× to -3.6×.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.